Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Evercore ISI Group Upgrades Enanta Pharmaceuticals to Outperform, Announces $62 Price Target

Evercore ISI Group analyst Liisa Bayko upgrades Enanta Pharmaceuticals (NASDAQ:ENTA) from In-Line to Outperform and announces $62 price target.
byBenzinga Newsdesk
July 6, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Evercore ISI Group analyst Liisa Bayko upgrades Enanta Pharmaceuticals (NASDAQ:ENTA) from In-Line to Outperform and announces $62 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

‘Hamas Fighters Trained In Iran Before Oct. 7 Attacks; Roughly 500 Palestinian Militants Got Specialized Combat Instruction At Iranian Facilities As Recently As September’ – WSJ

By Benzinga Newsdesk
October 25, 12:02 PM
https://www.wsj.com/world/middle-east/hamas-fighters-trained-in-iran-before-oct-7-attacks-e2a8dbb9In the weeks leading up to Hamas's Oct. 7 attack on Israel, hundreds of the Palestinian Islamist militant group's fighters

EIS